by Brian Hunt | Nov 4, 2021 | News
On this windy and rainy day in Chicago the KeraNeticsTM show crew wrapped up their booth exhibit at the 2021 ASTRO annual meeting. While attending the three-day conference, the crew had the opportunity to discuss KeraStat® Cream with key radiation oncology...
by Brian Hunt | Oct 29, 2021 | News
President Joe Biden recently appointed new board members to the National Cancer Advisory Board. Board members serve a six year term and are involved in federal initiatives related to cancer research in the United States. The National Cancer Advisory Board helps to...
by Brian Hunt | Jul 20, 2020 | News
Winston-Salem, N.C., July 20, 2020 – KeraNetics Inc. announces today that the next product in its KeraStat® wound dressing portfolio, KeraStat® Cream, has been cleared by the US Food and Drug Administration for indications of radiation dermatitis. This product is...
by Brian Hunt | Mar 21, 2018 | News
Winston-Salem, N.C., March 21, 2018 – KeraNetics™ announces today that the next product in its KeraStat® wound dressing portfolio, KeraStat® Cream, has begun pilot human clinical trial testing. The randomized open-label study is designed to evaluate the...
by Brian Hunt | Jun 2, 2017 | News
Winston-Salem, NC, June 2, 2017 – KeraNetics, LLC, the global leader in purified keratin medical products, announced today that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for KeraStat® Gel. KeraStat® Gel is a...
by Brian Hunt | Apr 27, 2017 | News
New Rochelle, NY, April 27, 2017—The use of human hair-derived keratin biomaterials to regenerate skeletal muscle has shown promise in new research that documents significant increases in both new muscle tissue formation and muscle function among mouse models of...
Recent Comments